Stockreport

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF cGMP Facility Streamlines Clinical & Commercial mRNA Drug Substance Development;Built by mRNA & Industry Experts to Meet Demand for mRNA-based Medicine SAN DIEGO--(BU [Read more]